Skip to content

Author

Anjali Anil

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

Clinicobacteriological profile, Mortality Predictors and Antimicrobial Resistance in Necrotising Soft Tissue Infections: A prospective study.

BACKGROUND Necrotising soft tissue infections (NSTIs) are rapidly progressive infections requiring prompt diagnosis and management. This study assessed predictors of mortality, microbiological spectrum, antimicrobial resistance patterns, and differences between polymicrobial and monomicrobial NSTIs in a prospective man...

A. Anil, Tanvi Vashist, Divya Nair et al. · 0 citations
Open access Aug 2026

Novel Therapeutics and Antifungal Agents

Next-generation azoles, such as oteseconazole and VT-1598, offer improved specificity for fungal sterol 14α-demethylase (CYP51) while reducing host toxicity, and new echinocandin derivatives, such as rezafungin, exhibit improved pharmacokinetics, enabling less frequent dosing.

Anjali Anil, A. Chakrabarti, Shivaprakash Mandya Rudramurthy · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.